Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo


Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Digital “Clones” Customize Cancer Treatmentf

If each one of us is biologically unique, why are our ailments so often treated with one-size-fits-all drug regimens? Optimata, an Israeli company based in Ramat Gan, aims to help doctors customize cancer treatments by building a software “clone” of each patient. The company’s system starts with a mathematical model that incorporates several hundred equations representing different bodily processes. Doctors then plug in data specific to the patient and his or her disease – the growth rates of the tumor and blood vessels, for example. The software allows the doctor to try out in the digital realm various combinations of drugs and dosing schedules in order to find the treatment regimen that will do the best job of fighting the cancer with the fewest side effects. Researchers are currently testing the system on breast cancer patients at the UK’s Nottingham City Hospital. If those trials are successful, Optimata could begin marketing the software as a workstation tool for physicians by 2007. The company is also developing digital treatment-optimization tools for diseases other than cancer.

Other short items of interest

If Only It Were This Easy

Cornell’s Minister of Technology

Microsoft Declares War on Spam

Guiding the Evolution of Things

So what are you reading these days?

Logging On to Your Lawyer

New Drugs Work

Mapping “Deep Place”

Digital “Clones” Customize Cancer Treatment

Cord Blood Makes the Cut

IPod Impact

Alternative Solar

75 Years in Technology Review

0 comments about this story. Start the discussion »

Tagged: Biomedicine

Reprints and Permissions | Send feedback to the editor

From the Archives


Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me